Filippo G. De Braud

Cancer Therapy : Clinical Phase I Study of NGR-hTNF , a Selective Vascular Targeting Agent , in Combination with Cisplatin in Refractory Solid Tumors

Roberto Scalamogna, Vanesa Gregorc, C. Bordignon, 2011 .